Aimei Health Technology Co., Ltd (AFJK) is a publicly traded company in the Financial Services sector, operating within the Shell Companies industry. The company is headquartered in New York City, NY, United States. The current CEO is Junheng Xie.
AFJK has IPO date of 2024-01-22, 2 full-time employees, listed on the NASDAQ Global Market, a market capitalization of $313.43M.
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
